SHFHOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Scientist Home Future Health Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.70+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $40.32M
- P/E (TTM)
- –
- Dividend yield
- –
Scientist Home Future Health Ltd revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | % of revenue | YoY |
|---|---|---|---|---|
| Retail Trading Business [Member] | $197.45K | – | 96.8% | – |
| Service Business [Member] | $6.61K | – | 3.2% | – |
By product or service
| Revenue | FY2025 | FY2024 | % of revenue | YoY |
|---|---|---|---|---|
| Scientist Home Mixed Gelatine Hydrolysate | $60.45K | – | 29.6% | – |
| Others (Delivery Fee) | $47.81K | – | 23.4% | – |
| Scientist Home High Concentration Proteinase | $43.75K | – | 21.4% | – |
| Scientist Home Vein Cream | $22.63K | – | 11.1% | – |
| Scientist Home Cholipolysis Cholic Acid | $13.39K | – | 6.6% | – |
| Scientist Home Bone Gelatine Hydrolysate | $9.42K | – | 4.6% | – |
By region
From the segment and revenue-disaggregation notes of Scientist Home Future Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.